New drug pricing plans will ‘damage UK biotech’
August 16, 2013Research and Development, Sales and Marketing BIA, Hunt, NHS, VBP, bates, biotech
The BioIndustry Association is warning that the government’s new drug pricing scheme could put future investment in the UK’s biotech …
Boehringer to shut down Petersburg chemicals facility
August 16, 2013Manufacturing and Production, Sales and Marketing Boehringer, Petersburg
Boehringer Ingelheim has conceded defeat in its search for a buyer for its chemicals facility in Petersburg, US, and is …
Price cut not enough for Pfizer’s Xalkori
August 16, 2013Sales and Marketing NICE, Pfizer, Xalkori, lung cancer
In final draft guidance NICE has rejected Pfizer’s new lung cancer drug Xalkori because of its high cost. The Institute …
Pharmstandard buys Singapore API firm to guarantee supply
August 16, 2013Manufacturing and Production OTC, Pharmstandard, bever
Russia’s largest drug company Pharmstandard has agreed a $590 million deal to buy the Singapore-based supplier of active pharmaceutical ingredients …
Cadence appoints Laureen DeBuono to its Board
August 16, 2013Manufacturing and Production, Medical Communications, Research and Development DeBuono, cadence
Biopharma firm Cadence Pharmaceuticals has appointed Laureen DeBuono to its Board of directors. “We are very pleased to welcome Ms …
GSK and Roche get EU breast cancer indication
August 15, 2013Sales and Marketing GSK, Herceptin, Roche, Tyverb, Xeloda, breast cancer
The European Commission has granted a new indication for the use of GSK’s breast cancer drug Tyverb in combination with …
Celgene’s multiple myeloma pill launched in UK
August 15, 2013Sales and Marketing Celgene, Velcade, low, myeloma
Celgene’s new oral blood cancer drug pomalidomide has been launched in the UK and Ireland as a third line treatment …
ABPI publishes trial disclosure ‘toolkit’
August 15, 2013Medical Communications, Sales and Marketing ABPI, EFPIA, Goldacre, transparency
The ABPI has today launched a new clinical trial disclosure toolkit to help pharma companies meet data transparency requirements. The …
Astellas hires senior VP from rival Takeda
August 15, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Takeda, oncology
Astellas has appointed Claire Thom from fellow Japanese firm Takeda to be senior vice president of its global oncology development. …
HIV pill Tivicay gains FDA approval
August 14, 2013Sales and Marketing FDA, GSK, Tivicay, ViiV
ViiV and partner GlaxoSmithKline’s new HIV drug Tivicay has been shown the FDA’s green light for distribution in the US. …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
